EGFR and glioblastoma: Considering this, we decided to explore this area of cellular biochemistry in-depth, focusing on the effect of IS20 derivatives on cellular metabolism, redox disruption, EGFR/mTOR signaling and cell cycle progression in glioblastoma and leukemia cells with altered p53 status.